Redox homeostasis, Thiol-dependent reductase 1 TDR1 PE=1 SV=1 - [A4I8P2_LEIIN]
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | yes | yes: 4 |
Forrest at al. (procyclic) | yes | yes: 4 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A0A3S7X699
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 8 |
GO:0015035 | protein-disulfide reductase activity | 3 | 6 |
GO:0015036 | disulfide oxidoreductase activity | 4 | 6 |
GO:0015038 | glutathione disulfide oxidoreductase activity | 5 | 3 |
GO:0016209 | antioxidant activity | 1 | 3 |
GO:0016491 | oxidoreductase activity | 2 | 6 |
GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors | 3 | 6 |
GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor | 4 | 6 |
GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor | 4 | 3 |
GO:0016740 | transferase activity | 2 | 4 |
GO:0019153 | protein-disulfide reductase (glutathione) activity | 4 | 6 |
GO:0045174 | glutathione dehydrogenase (ascorbate) activity | 2 | 3 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 6 |
GO:0000166 | nucleotide binding | 3 | 1 |
GO:0005488 | binding | 1 | 2 |
GO:0036094 | small molecule binding | 2 | 1 |
GO:0043167 | ion binding | 2 | 1 |
GO:0043168 | anion binding | 3 | 1 |
GO:0050661 | NADP binding | 4 | 1 |
GO:0070402 | NADPH binding | 4 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901265 | nucleoside phosphate binding | 3 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
GO:0005515 | protein binding | 2 | 1 |
GO:0042802 | identical protein binding | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 125 | 127 | PF00675 | 0.351 |
CLV_NRD_NRD_1 | 252 | 254 | PF00675 | 0.483 |
CLV_NRD_NRD_1 | 440 | 442 | PF00675 | 0.500 |
CLV_NRD_NRD_1 | 445 | 447 | PF00675 | 0.567 |
CLV_PCSK_FUR_1 | 443 | 447 | PF00082 | 0.588 |
CLV_PCSK_KEX2_1 | 125 | 127 | PF00082 | 0.373 |
CLV_PCSK_KEX2_1 | 377 | 379 | PF00082 | 0.483 |
CLV_PCSK_KEX2_1 | 442 | 444 | PF00082 | 0.596 |
CLV_PCSK_KEX2_1 | 445 | 447 | PF00082 | 0.616 |
CLV_PCSK_KEX2_1 | 65 | 67 | PF00082 | 0.444 |
CLV_PCSK_PC1ET2_1 | 125 | 127 | PF00082 | 0.381 |
CLV_PCSK_PC1ET2_1 | 377 | 379 | PF00082 | 0.483 |
CLV_PCSK_PC1ET2_1 | 442 | 444 | PF00082 | 0.480 |
CLV_PCSK_PC1ET2_1 | 65 | 67 | PF00082 | 0.427 |
CLV_PCSK_PC7_1 | 441 | 447 | PF00082 | 0.574 |
CLV_PCSK_SKI1_1 | 170 | 174 | PF00082 | 0.381 |
CLV_PCSK_SKI1_1 | 4 | 8 | PF00082 | 0.423 |
CLV_PCSK_SKI1_1 | 427 | 431 | PF00082 | 0.379 |
CLV_PCSK_SKI1_1 | 66 | 70 | PF00082 | 0.444 |
DEG_SCF_FBW7_2 | 283 | 289 | PF00400 | 0.483 |
DOC_CKS1_1 | 283 | 288 | PF01111 | 0.381 |
DOC_CKS1_1 | 421 | 426 | PF01111 | 0.386 |
DOC_CYCLIN_RxL_1 | 1 | 11 | PF00134 | 0.456 |
DOC_MAPK_DCC_7 | 52 | 60 | PF00069 | 0.381 |
DOC_MAPK_gen_1 | 253 | 259 | PF00069 | 0.394 |
DOC_MAPK_MEF2A_6 | 52 | 60 | PF00069 | 0.381 |
DOC_WW_Pin1_4 | 202 | 207 | PF00397 | 0.532 |
DOC_WW_Pin1_4 | 282 | 287 | PF00397 | 0.381 |
DOC_WW_Pin1_4 | 420 | 425 | PF00397 | 0.386 |
LIG_14-3-3_CanoR_1 | 198 | 202 | PF00244 | 0.450 |
LIG_14-3-3_CanoR_1 | 247 | 255 | PF00244 | 0.323 |
LIG_14-3-3_CterR_2 | 445 | 450 | PF00244 | 0.491 |
LIG_Actin_WH2_2 | 156 | 172 | PF00022 | 0.444 |
LIG_APCC_ABBA_1 | 239 | 244 | PF00400 | 0.450 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.531 |
LIG_BRCT_BRCA1_1 | 235 | 239 | PF00533 | 0.405 |
LIG_EH1_1 | 331 | 339 | PF00400 | 0.483 |
LIG_eIF4E_1 | 332 | 338 | PF01652 | 0.483 |
LIG_FHA_1 | 55 | 61 | PF00498 | 0.411 |
LIG_FHA_2 | 154 | 160 | PF00498 | 0.483 |
LIG_FHA_2 | 430 | 436 | PF00498 | 0.576 |
LIG_GBD_Chelix_1 | 34 | 42 | PF00786 | 0.444 |
LIG_Integrin_RGD_1 | 314 | 316 | PF01839 | 0.556 |
LIG_LIR_Gen_1 | 30 | 38 | PF02991 | 0.471 |
LIG_LIR_Gen_1 | 401 | 412 | PF02991 | 0.387 |
LIG_LIR_Nem_3 | 213 | 218 | PF02991 | 0.529 |
LIG_LIR_Nem_3 | 236 | 242 | PF02991 | 0.405 |
LIG_LIR_Nem_3 | 269 | 274 | PF02991 | 0.398 |
LIG_LIR_Nem_3 | 30 | 34 | PF02991 | 0.426 |
LIG_LIR_Nem_3 | 401 | 407 | PF02991 | 0.370 |
LIG_LIR_Nem_3 | 428 | 433 | PF02991 | 0.377 |
LIG_MYND_3 | 55 | 59 | PF01753 | 0.483 |
LIG_PCNA_TLS_4 | 96 | 103 | PF02747 | 0.483 |
LIG_Pex14_2 | 396 | 400 | PF04695 | 0.466 |
LIG_PTB_Apo_2 | 326 | 333 | PF02174 | 0.483 |
LIG_PTB_Phospho_1 | 326 | 332 | PF10480 | 0.483 |
LIG_REV1ctd_RIR_1 | 371 | 382 | PF16727 | 0.483 |
LIG_SH2_CRK | 235 | 239 | PF00017 | 0.366 |
LIG_SH2_CRK | 271 | 275 | PF00017 | 0.405 |
LIG_SH2_CRK | 31 | 35 | PF00017 | 0.454 |
LIG_SH2_CRK | 46 | 50 | PF00017 | 0.264 |
LIG_SH2_GRB2like | 235 | 238 | PF00017 | 0.411 |
LIG_SH2_GRB2like | 273 | 276 | PF00017 | 0.405 |
LIG_SH2_NCK_1 | 31 | 35 | PF00017 | 0.480 |
LIG_SH2_PTP2 | 273 | 276 | PF00017 | 0.405 |
LIG_SH2_SRC | 135 | 138 | PF00017 | 0.359 |
LIG_SH2_SRC | 273 | 276 | PF00017 | 0.405 |
LIG_SH2_STAP1 | 235 | 239 | PF00017 | 0.483 |
LIG_SH2_STAP1 | 31 | 35 | PF00017 | 0.486 |
LIG_SH2_STAP1 | 404 | 408 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 135 | 138 | PF00017 | 0.365 |
LIG_SH2_STAT5 | 150 | 153 | PF00017 | 0.420 |
LIG_SH2_STAT5 | 273 | 276 | PF00017 | 0.480 |
LIG_SH2_STAT5 | 300 | 303 | PF00017 | 0.358 |
LIG_SH2_STAT5 | 332 | 335 | PF00017 | 0.416 |
LIG_SH2_STAT5 | 77 | 80 | PF00017 | 0.338 |
LIG_SH2_STAT5 | 9 | 12 | PF00017 | 0.415 |
LIG_SH3_3 | 257 | 263 | PF00018 | 0.462 |
LIG_SUMO_SIM_anti_2 | 159 | 164 | PF11976 | 0.328 |
LIG_SUMO_SIM_anti_2 | 383 | 388 | PF11976 | 0.358 |
LIG_TRAF2_1 | 432 | 435 | PF00917 | 0.562 |
LIG_TYR_ITIM | 233 | 238 | PF00017 | 0.366 |
LIG_TYR_ITIM | 29 | 34 | PF00017 | 0.418 |
LIG_UBA3_1 | 386 | 394 | PF00899 | 0.390 |
MOD_CDK_SPxxK_3 | 420 | 427 | PF00069 | 0.386 |
MOD_CK2_1 | 197 | 203 | PF00069 | 0.371 |
MOD_CK2_1 | 429 | 435 | PF00069 | 0.542 |
MOD_Cter_Amidation | 375 | 378 | PF01082 | 0.405 |
MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.366 |
MOD_GlcNHglycan | 121 | 124 | PF01048 | 0.472 |
MOD_GlcNHglycan | 221 | 224 | PF01048 | 0.579 |
MOD_GlcNHglycan | 286 | 289 | PF01048 | 0.483 |
MOD_GlcNHglycan | 308 | 311 | PF01048 | 0.479 |
MOD_GlcNHglycan | 399 | 403 | PF01048 | 0.417 |
MOD_GlcNHglycan | 79 | 83 | PF01048 | 0.538 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.477 |
MOD_GSK3_1 | 197 | 204 | PF00069 | 0.346 |
MOD_GSK3_1 | 425 | 432 | PF00069 | 0.412 |
MOD_N-GLC_1 | 142 | 147 | PF02516 | 0.483 |
MOD_NEK2_1 | 68 | 73 | PF00069 | 0.344 |
MOD_NEK2_1 | 78 | 83 | PF00069 | 0.479 |
MOD_NEK2_1 | 8 | 13 | PF00069 | 0.396 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.392 |
MOD_PIKK_1 | 291 | 297 | PF00454 | 0.408 |
MOD_PKA_2 | 197 | 203 | PF00069 | 0.338 |
MOD_PKA_2 | 276 | 282 | PF00069 | 0.325 |
MOD_PKA_2 | 51 | 57 | PF00069 | 0.338 |
MOD_PKB_1 | 245 | 253 | PF00069 | 0.269 |
MOD_Plk_1 | 153 | 159 | PF00069 | 0.418 |
MOD_Plk_4 | 336 | 342 | PF00069 | 0.490 |
MOD_Plk_4 | 425 | 431 | PF00069 | 0.317 |
MOD_Plk_4 | 68 | 74 | PF00069 | 0.496 |
MOD_ProDKin_1 | 202 | 208 | PF00069 | 0.532 |
MOD_ProDKin_1 | 282 | 288 | PF00069 | 0.381 |
MOD_ProDKin_1 | 420 | 426 | PF00069 | 0.386 |
MOD_SUMO_for_1 | 348 | 351 | PF00179 | 0.411 |
MOD_SUMO_rev_2 | 346 | 350 | PF00179 | 0.432 |
TRG_DiLeu_BaEn_2 | 321 | 327 | PF01217 | 0.483 |
TRG_DiLeu_BaLyEn_6 | 408 | 413 | PF01217 | 0.483 |
TRG_ENDOCYTIC_2 | 179 | 182 | PF00928 | 0.338 |
TRG_ENDOCYTIC_2 | 215 | 218 | PF00928 | 0.554 |
TRG_ENDOCYTIC_2 | 235 | 238 | PF00928 | 0.153 |
TRG_ENDOCYTIC_2 | 271 | 274 | PF00928 | 0.411 |
TRG_ENDOCYTIC_2 | 31 | 34 | PF00928 | 0.393 |
TRG_ENDOCYTIC_2 | 404 | 407 | PF00928 | 0.344 |
TRG_ENDOCYTIC_2 | 46 | 49 | PF00928 | 0.268 |
TRG_ER_diArg_1 | 245 | 248 | PF00400 | 0.381 |
TRG_ER_diArg_1 | 440 | 443 | PF00400 | 0.530 |
TRG_NLS_MonoExtC_3 | 440 | 445 | PF00514 | 0.419 |
TRG_NLS_MonoExtN_4 | 441 | 446 | PF00514 | 0.432 |
TRG_Pf-PMV_PEXEL_1 | 216 | 221 | PF00026 | 0.564 |
TRG_Pf-PMV_PEXEL_1 | 431 | 435 | PF00026 | 0.511 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4IX62 | Bodo saltans | 40% | 94% |
A0A0S4KHM5 | Bodo saltans | 40% | 93% |
A0A1X0P247 | Trypanosomatidae | 46% | 100% |
A0A422NGA2 | Trypanosoma rangeli | 51% | 100% |
A4HJ18 | Leishmania braziliensis | 80% | 100% |
A4I8P2 | Leishmania infantum | 100% | 100% |
E9B3K3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q70GE8 | Leishmania major | 96% | 100% |
V5DBY4 | Trypanosoma cruzi | 48% | 100% |